Mesenchymal Stem Cells As A Therapeutic Option For Patients With ALS
- *Corresponding Author:
- Katarzyna Pawelec
Department of Pediatrics, Hematology and Oncology Medical University of Warsaw
Zwirki I Wigury 63A, 02-091 Warszawa, Poland
Tel: +4822 22 317 96 21
Fax: +4822 22 317 96 21
E-mail: [email protected]
Received March 9, 2016 ; Accepted April 21, 2016; Published April 27, 2016
Citation: Boruczkowski D, Gladysz D, Grudniak M, Kosterna K, Pawelec K (2016) Mesenchymal Stem Cells As A Therapeutic Option For Patients With ALS. Gen Med (Los Angel) 4:235. doi:10.4172/2327-5146.1000235
Copyright: © 2016 Boruczkowski D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
It has been postulated that mesenchymal stem cells could play a role in treatment of patients with amyotrophic lateral sclerosis. Variety of mechanism behind MSC action has been proposed including immunomodulation and delivery of trophic factors. The scientific rationale in preclinical studies is being proved along with first clinical uses. Recent advances in stem cell research rises new hope for patients with ALS.